You are using an older browser version. Please use a supported version for the best MSN experience.

GSK focused on split as cost checks, COVID-19 easings aid earnings

Drugs giant GlaxoSmithKline says it's making good progress on plans to split into two parts next year as part of moves by boss Emma Walmsley to deliver more value for shareholders. Julian Satterthwaite reports.
image beaconimage beaconimage beacon